Publicaciones (38) Publicaciones de Maria Santisimo Sacramento Diaz Carrasco

2024

  1. GEDEFO-SEFH management of antineoplastic extravasations survey results

    Journal of Oncology Pharmacy Practice, Vol. 30, Núm. 1, pp. 67-77

2023

  1. N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study

    Annals of Hematology, Vol. 102, Núm. 8, pp. 2069-2075

2022

  1. Antineoplastic extravasation management: Consensus of the Spanish Oncology Pharmacy Group (GEDEFO)

    Journal of Oncology Pharmacy Practice, Vol. 28, Núm. 5, pp. 1170-1181

2021

  1. Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 198-203

  2. Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 184-192

2020

  1. Predictive biomarkers of response to immune checkpoint inhibitors

    Farmacia Hospitalaria, Vol. 44, Núm. 4, pp. 141-148

2019

  1. Prevalencia de factores ambientales, hormonales y reproductivos de riesgo asociados al cáncer de mama en una población en estadio precoz

    IV Jornadas Doctorales Escuela Internacional de Doctorado de la Universidad de Murcia (Eidum)

  2. Variability of carboplatin dose calculation methods in Spain

    Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 7, pp. 1551-1557

2018

  1. Observational study of drug-drug interactions in oncological inpatients

    Farmacia Hospitalaria, Vol. 42, Núm. 1, pp. 10-15

2017

  1. Controversias sobre los criterios de dosificaciónde carboplatino en pacientes obesos

    III Jornadas Doctorales Escuela Internacional de Doctorado de la Universidad de Murcia (EIDUM)

  2. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological adult patients

    Farmacia Hospitalaria, Vol. 41, Núm. 5, pp. 611-617

  3. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients

    International Journal of Clinical Pharmacy, Vol. 39, Núm. 1, pp. 126-132

  4. Intensidad de dosis recibida en pacientes con Cáncer de Mama Precoz en Tratamiento Adyuvante

    III Jornadas Doctorales Escuela Internacional de Doctorado de la Universidad de Murcia (EIDUM)

  5. Practical aspects of the use of intrathecal chemotherapy

    Farmacia Hospitalaria, Vol. 41, Núm. 1, pp. 105-129

2016

  1. Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use

    Journal of Oncology Pharmacy Practice, Vol. 22, Núm. 5, pp. 659-665

2015

  1. Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 6, pp. 1021-1027

2014

  1. Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients

    International Journal of Clinical Pharmacy, Vol. 36, Núm. 6, pp. 1160-1169

  2. Reacción infusional grave e infrecuente por trastuzumab

    Farmacia Hospitalaria, Vol. 38, Núm. 3, pp. 254-255

2013

  1. Clonazepam for seizure prophylaxis in adult patients treated with high dose busulfan

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 3, pp. 339-343

  2. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 6, pp. 1105-1112